Catalyst Wire Dossier Catalyst Wire Dossier

ATTO-1310

· Attovia Therapeutics Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATTO-1310, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus [Phase 1]

See pricing